Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer.

Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer. - Sentinel lymph node biopsy in breast cancer using SPIO

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030127

Enrollment

Registered

2017-12-01

Start date

2008-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Superparamagnetic iron oxide and patent blue dye were injected in the subareolar breast tissue. Following a few minutes of massage to promote migration of iron tracer and blue dye throughout the lymph

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: patients with clinically node-negative breast cancer

Exclusion criteria

Exclusion criteria: clinically node-positive patients patients received preoperative chemotherapy male breast cancer

Design outcomes

Primary

Measure	Time frame
To assess rate of identification, sensitivity and false negative in this procedure	—

Countries

Japan

Contacts

Public ContactMikio Shiozawa

Jichi Medical University Department of Surgery

shiozawa@jichi.ac.jp0285587371

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026